IMC Chicago
ARKG icon

IMC Chicago’s ARK Genomic Revolution ETF ARKG Stock Holding History

IMC Chicago’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.56M Buy
132,100
+17,900
+16% +$570K ﹤0.01% 2012
2026
Q1 		$3.02M Sell
114,200
-101,300
-47% -$2.97M ﹤0.01% 2211
2025
Q4 		$6.24M Buy
215,500
+25,400
+13% +$762K ﹤0.01% 1569
2025
Q3 		$5.28M Sell
190,100
-40,800
-18% -$1.03M ﹤0.01% 1530
2025
Q2 		$5.62M Sell
230,900
-14,900
-6% -$326K ﹤0.01% 1318
2025
Q1 		$5.1M Buy
245,800
+17,500
+8% +$440K ﹤0.01% 1220
2024
Q4 		$5.38M Buy
228,300
+4,200
+2% +$103K ﹤0.01% 1191
2024
Q3 		$5.74M Sell
224,100
-42,900
-16% -$1.09M ﹤0.01% 1072
2024
Q2 		$6.27M Buy
267,000
+38,100
+17% +$962K ﹤0.01% 967
2024
Q1 		$6.58M Sell
228,900
-66,200
-22% -$1.99M ﹤0.01% 864
2023
Q4 		$9.68M Buy
295,100
+258,700
+711% +$7.03M 0.01% 658
2023
Q3 		$1.01M Sell
36,400
-14,400
-28% -$471K ﹤0.01% 1221
2023
Q2 		$1.73M Sell
50,800
-29,600
-37% -$930K ﹤0.01% 926
2023
Q1 		$2.42M Buy
80,400
+24,700
+44% +$765K ﹤0.01% 802
2022
Q4 		$1.57M Sell
55,700
-27,600
-33% -$876K ﹤0.01% 889
2022
Q3 		$2.74M Sell
83,300
-19,100
-19% -$701K ﹤0.01% 685
2022
Q2 		$3.23M Sell
102,400
-87,700
-46% -$3.07M ﹤0.01% 613
2022
Q1 		$8.73M Sell
190,100
-39,500
-17% -$1.88M 0.01% 483
2021
Q4 		$14.1M Buy
229,600
+89,000
+63% +$6.15M 0.01% 428
2021
Q3 		$10.5M Buy
140,600
+10,800
+8% +$906K 0.01% 482
2021
Q2 		$12M Sell
129,800
-72,000
-36% -$6.12M 0.01% 420
2021
Q1 		$17.9M Buy
+201,800
New +$20M 0.03% 317

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

IMC Chicago's ARKG Position: Q2 2026 in Review

IMC Chicago opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 13,835 shares worth $582K. The stake represents ﹤0.01% of the portfolio and ranks #4470 among its holdings. This is a return to the name: IMC Chicago previously reported a position in ARKG as recently as Q3 2025.

IMC Chicago first reported a position in ARKG in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.96M in Q2 2025. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • IMC Chicago held 13,835 shares of ARK Genomic Revolution ETF worth $582K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new IMC Chicago position in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4470 holding.
  • IMC Chicago first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 9 quarters since.
  • IMC Chicago's ARK Genomic Revolution ETF position peaked at $1.96M in Q2 2025.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.